GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) » Definitions » Capital Expenditure

ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) Capital Expenditure : kr-2.02 Mil (TTM As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is ExpreS2ion Biotech Holding AB Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

ExpreS2ion Biotech Holding AB's cash flow for capital expenditures for the three months ended in Dec. 2023 was kr-0.02 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2023 was kr-2.02 Mil.

ExpreS2ion Biotech Holding AB Capital Expenditure Historical Data

The historical data trend for ExpreS2ion Biotech Holding AB's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ExpreS2ion Biotech Holding AB Capital Expenditure Chart

ExpreS2ion Biotech Holding AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.68 -0.89 -0.72 -0.38 -2.02

ExpreS2ion Biotech Holding AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.19 -1.22 -0.75 -0.03 -0.02

ExpreS2ion Biotech Holding AB Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-2.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) » Definitions » Capital Expenditure
Comparable Companies
XSAT:ABERA NGM:COEGIN OSTO:COMBI OSTO:SCOL OSTO:LPGO OSTO:BIOSGN XSAT:CHOSA OSTO:2CUREX XSAT:RESP XSAT:APTA OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
5JD:Germany
Address
c/o Mindpark, Ronnowsgatan 8c, Helsingborg, SWE, S-252 25
Website
https://www.expres2ionbio.com
ExpreS2ion Biotech Holding AB has developed a technology platform, ExpreS2, for fast and efficient non-clinical development and production of complex proteins for new vaccines and diagnostics. ExpreS2 is regulatorily validated for clinical supply. The platform includes functionally modified glycosylation variants for enhanced immunogenicity and pharmacokinetics. The company has produced more than 500 proteins and virus-like particles (VLPs) in collaboration with research institutions and companies.

ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) Headlines

No Headlines